152 related articles for article (PubMed ID: 21850396)
1. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
[TBL] [Abstract][Full Text] [Related]
2. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
7. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
Gudina AT; Copeland G; Soliman AS; Hirko KA
Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
[TBL] [Abstract][Full Text] [Related]
13. Incidence of inflammatory breast cancer in women, 1992-2009, United States.
Goldner B; Behrendt CE; Schoellhammer HF; Lee B; Chen SL
Ann Surg Oncol; 2014 Apr; 21(4):1267-70. PubMed ID: 24366421
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
Aurit SJ; Devesa SS; Soliman AS; Schairer C
Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
[TBL] [Abstract][Full Text] [Related]
15. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
Abraham HG; Xia Y; Mukherjee B; Merajver SD
Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
[TBL] [Abstract][Full Text] [Related]
17. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.
Aguiar MAN; Wanderley CWS; Nobre LMS; Alencar MRM; Saldanha MDPS; Souza AM; Wong DVT; Barros PG; Almeida PRC; Lima-Júnior RCP; Ribeiro RA
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e138-e144. PubMed ID: 28766916
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
Arias-Pulido H; Cimino-Mathews AM; Chaher N; Qualls CR; Joste N; Colpaert C; Marotti JD; Chamberlin MD; Foisey MG; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2021 Dec; 190(3):477-489. PubMed ID: 34542773
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for inflammatory breast cancer and other invasive breast cancers.
Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
